← Back to Search

Messaging Strategies + Financial Incentive for Lung Cancer Screening Eligibility

N/A

Waitlist Available

Led By Katharine A Rendle, PhD,MSW,MPH

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial tests different messages to increase response rates to a survey that estimates eligibility for lung cancer screening. This helps improve future interventions to increase screening.

Who is the study for?

This trial is for people aged 50-80 who've had a primary care visit at Penn Medicine between 2020-2025 and are eligible for lung cancer screening. It's not for those with a history of lung cancer, who've completed lung cancer screening at Penn Medicine, or don't want to be contacted for research.Check my eligibility

What is being tested?

The study is testing how different types of messages affect the response rates to a survey estimating eligibility for lung cancer screening. The goal is to find the most effective messaging strategy to encourage participation in future screenings.See study design

What are the potential side effects?

Since this trial involves only receiving informational messages and completing surveys, there are no medical side effects associated with traditional clinical trials that test drugs or medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Full Survey Completion

Secondary outcome measures

Partial Survey Completion

Trial Design

12Treatment groups

Experimental Treatment

Group I: Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (CA) plus an incentive

Group II: Arm 8 (Introductory Message B + Tobacco Use Message B)Experimental Treatment2 Interventions

Participants will receive two framed messages (BB)

Group III: Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (BB) plus an incentive

Group IV: Arm 6 (Introductory Message B + Tobacco Use Message A)Experimental Treatment2 Interventions

Participants will receive two framed messages (BA)

Group V: Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (BA) plus an incentive

Group VI: Arm 4 (Introductory Message A + Tobacco Use Message B)Experimental Treatment2 Interventions

Participants will receive two framed messages (AB)

Group VII: Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (AB) plus an incentive

Group VIII: Arm 2 (Introductory Message A + Tobacco Use Message A)Experimental Treatment2 Interventions

Participants will receive two framed messages (AA)

Group IX: Arm 12 (Introductory Message C + Tobacco Use Message B)Experimental Treatment2 Interventions

Participants will receive two framed messages (CB)

Group X: Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (CB) plus an incentive

Group XI: Arm 10 (Introductory Message C + Tobacco Use Message A)Experimental Treatment2 Interventions

Participants will receive two framed message (CA)

Group XII: Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)Experimental Treatment3 Interventions

Participants will receive two framed messages (AA) plus an incentive

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Financial Incentive

2016

N/A

~63450

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,927,667 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,946,579 Total Patients Enrolled

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

139,695 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this research project?

"This clinical trial is recruiting up to 6000 individuals with lung cancer between the ages of 50 and 80. Applicants must meet these criteria in order to be considered for enrolment."

Answered by AI

Is this research open to participants aged 55 and over?

"The age range for this clinical trial is between 50 and 80. All participants must be within these ages in order to meet the eligibility standards of the study."

Answered by AI

Does this research have any open enrollment opportunities?

"Affirmative, clinicaltrials.gov lists the trial as currently enrolling. This research began to be advertised on July 31st 2023 with a most recent update occurring November 10th of that same year. 6000 participants are desperately needed from 1 medical centre for this important study."

Answered by AI

How many participants are eligible to join this investigation?

"Indeed, clinicaltrials.gov corroborates that this medical study is currently recruiting participants; first posted on July 31st 2023 and most recently updated November 10th 2023. This research requires 6000 individuals from a single site to be enrolled in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lung Cancer Screening Eligibility Assessment

Katharine Rendle 2023. "Lung Cancer Screening Eligibility Assessment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06133816.